Fontem LLC, the parent to Blu products, is expected to appeal the regulatory agency's decision.Read More
Tags :Marketing Denial Order
The three-judge panel also held that the FDA did not arbitrarily or capriciously deny Lotus' PMTAs.Read More
The agency said the product applications covered a variety of flavored e-cigarettes, including menthol.Read More
The company expects sales of its Bidi Vapor disposable to pick up in the second quarter of 2023. Read More
The order was granted as a temporary stay pending a motion to file a stay with the court by Feb. 1, 2023.Read More
Morgan Stanley said it expected the rejected products to remain on the U.S. market until a court decision.Read More
The products include the Vuse Vibe Tank Menthol 3.0% and the Vuse Ciro Cartridge Menthol 1.5%.Read More
The court will consider a further motion from Logic regarding the MDO that the company has seven days to file.Read More
The FDA’s recent rejection of logic products is based on questionable statistics, says Neil McKeganey.Read More
The e-cigarette manufacturer believes that the marketing denial was substantively and procedurally flawed. Read More